Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation in the Annual e:Med Meeting on Systems Medicine 2016 in Kiel, Germany on October 4-6, 2016. Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath, will present a keynote presentation titled "Quantitative Modeling and Simulation Approaches: Providing Deep Biological Hypotheses and Driving Critical Decisions from Research through Clinical Trials for Inflammation and Immunology" onTuesday October 4, 2016. Dr. Lore Gruenbaum, PhD, Executive Director of Biology and Pharmacology, will participate in a panel discussing the direction of the future of medicine.
Additionally, Dr. Gruenbaum will present on "Quantitative Systems Pharmacology: Applications in Drug Development" at theFirst International Symposium on Systems Medicine of Chronic Inflammatory Disorders (sysINFLAME) also being held in Kiel,Germany on October 6-7, 2016.
"We have made significant advances incorporating quantitative modeling and simulation into immunology and oncology programs. We are privileged to have been invited to share our work in these areas at the e:MED and sysINFLAME conferences."
Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath